Boeing Has a Record $745 Billion Backlog and Can't Build the Planes Fast Enough

Boeing reported a record $745.4B backlog, including $611.8B in commercial orders, but slower production and rising costs cloud the recovery and cash-flow outlook. Q3 core loss was $0.34 per share versus $0.201 expected, and commercial airplanes lost $697M with a -6.5% operating margin; management expects 737 deliveries to fall short of its 500 target and now targets 737 Rate 52 in the second half of 2027. Boeing shares fell 10.7% to $168.18, a new 52-week low, as the company projected about $2B of free cash flow in 2026 and $6B in 2028, with its $10B target in 2029.

Analysis

The backlog is demand insurance, not near-term cash-flow protection: Boeing monetizes it only as aircraft clear a constrained production system. With wings, fuselages and engines pacing output, slower rates extend working-capital absorption and keep investors exposed to cost growth before deliveries convert to cash. The key equity variable is therefore delivery cadence and unit economics—not order intake. The commercial margin miss makes a simple “demand is intact” bull case insufficient; defense growth may diversify revenue but does not by itself offset commercial execution risk.

Near term, the sharp selloff raises the hurdle for fresh outright shorts, but a November delivery update that confirms weakness could renew estimate cuts and pressure the recovery multiple. Over 1–3 months, track monthly 737 deliveries, supplier recovery and any change to cash-flow guidance. Over 6–18 months, Rate 52, 787 engine availability and 777X certification are separate execution gates; slippage in any one could defer cash conversion again. The contrarian point: the market may be treating a slower timeline as a broken recovery, while the durable backlog and defense business provide a floor—but that floor is conditional on financing the delay without further cost or balance-sheet deterioration. The thesis is falsified by sustained delivery improvement alongside narrowing commercial losses and cash-flow guidance holding; it strengthens if deliveries weaken or guidance is cut.

Key Decisions for Investors

• Avoid chasing the post-earnings move with an unhedged short at the fresh low. For bearish exposure, consider a defined-risk BA put spread only if November delivery data disappoints and option pricing still offers acceptable premium; the catalyst is execution, not another backlog announcement.
• Keep BA underweight versus a diversified aerospace/defense basket until monthly deliveries and commercial margins stabilize. Do not assume defense growth alone offsets commercial cash conversion risk.
• Treat an Airbus relative-value long as a watchlist hedge, not an automatic pair: Boeing’s execution problems can support competitor pricing or share capture, but verify Airbus production capacity, delivery trends and relative valuation before entering.
• Escalate the downside thesis if Boeing lowers its 2026/2028 free-cash-flow path, reports further abnormal supplier costs, or monthly 737 deliveries deteriorate. Reassess toward neutral if delivery cadence improves and commercial losses narrow without additional schedule slippage.